CDC7 and benign prostatic hyperplasia: We found that the majority of prostate cancer cell lines express high levels of CDC7 transcripts when compared to a benign prostate hyperplasia (BPH-1) cell line and a transformed prostate cell line with low malignant potential, WPE1-NA22 (Fig. 1A).